Hutchison Chi-Med has signed up the University of Cambridge to investigate the potential healing and anti-aging properties of a number of the group’s herbal remedies. Aim-listed Chi-Med sells traditional medicines in China and also has a research and development laboratory in Shanghai where its scientists analyse herbal remedies, some dating back 2,000 years, to establish their active ingredients.

For the full story, Click Here

Angiotech Pharmaceuticals, Inc. has launched the Tan EndoGlide(TM) Endothelium Insertion System in the United States. Angiotech holds exclusive U.S. distribution rights to market and distribute the Tan EndoGlide Endothelium Insertion System. The Tan EndoGlide is a device used to facilitate insertion of a donor endothelium during Endothelial Keratoplasty. The device is used by Ophthalmologists adapting to newer techniques to replace diseased corneal endothelium.

A new study conducted by a team led by Rob McConnell, professor at the University of Southern California (USC), indicated that children of stressed parents are more likely to develop asthma triggered by air pollution. Researchers found that stress and low parental education were also linked with larger effects of exposure to tobacco smoke during pregnancy.

Research conducted at University of Exeter, shows for the first time that a group-based psychological treatment, Mindfulness Based Cognitive Therapy (MBCT), could be a viable alternative to prescription drugs for people suffering from long-term depression. In a study, published in the Journal of Consulting and Clinical Psychology, MBCT proved as effective as maintenance anti-depressants in preventing a relapse and more effective in enhancing peoples’ quality of life. The study also showed MBCT to be as cost-effective as prescription drugs in helping people with a history of depression stay well in the longer-term.

A research conducted on a large patient population in the U.S. have shown that the use of the anti-inflammatory and painkiller ibuprofen is linked to lower risk of developing Alzheimer’s disease. According to the researchers, patients who took the drug for over 5 years were 40% less likely to develop the disease compared with patients who did not use that type of drug at all.